(Q40150459)

17 September 2017

1 reference

title

Aspirin in the treatment of juvenile arthritis (English)

1 reference

17 September 2017

1 reference

J. Baum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6344620

3 October 2023

language of work or name

English

0 references

publication date

1 June 1983

1 reference

17 September 2017

14 June 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6344620

full work available at URL

3 October 2023

https://api.elsevier.com/content/article/PII:0002934383905235?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

https://api.elsevier.com/content/article/PII:0002934383905235?httpAccept=text/plain

3 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

American Journal of Medicine

3 October 2023

published in

1 reference

17 September 2017

74

1 reference

17 September 2017

6A

1 reference

17 September 2017

10-15

1 reference

Comparison of cortisone and aspirin in treatment of juvenile rheumatoid arthritis.

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis

3 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Dosage of salicylates for children with juvenile rheumatoid arthritis. A prospective clinical trial with three different preparations of acetylsalicylic acid

3 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Salicylate therapy in juvenile rheumatoid arthritis. Dose, serum level, and toxicity

3 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Benorylate in management of Still's disease.

3 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration

3 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa

3 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

3 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Regular and enteric coated aspirin: A reevaluation

3 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Compliance With Salicylate Therapy in Adolescents With Juvenile Rheumatoid Arthritis

3 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Free versus bound salicylate concentration in adults and children with chronic inflammatory joint disease: serum albumin and other potential factors affecting the levels

3 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Total and free salicylate concentrations in juvenile rheumatoid arthritis

3 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Hepatoxicity with encephalopathy associated with aspirin therapy in rheumatoid arthritis

3 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Acute liver failure and encephalopathy (Reye's syndrome?) during salicylate therapy.

3 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis

3 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis a prospective study

3 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90523-5

3 October 2023

Identifiers

1 reference

17 September 2017

1 reference